Current status and prospects of robot-assisted laparoscopic partial hepatectomy in the treatment of liver cancer
10.3760/cma.j.cn115396-20250407-00082
- VernacularTitle:机器人辅助腹腔镜下肝部分切除术在肝癌治疗中的应用现状与展望
- Author:
Shounan LU
1
;
Zhanzhi MENG
;
Yong MA
Author Information
1. 哈尔滨医科大学附属第一医院肝脏微创外科，哈尔滨 150001
- Keywords:
Liver neoplasms;
Surgical procedures, minimally invasive;
Hepatectomy;
Robot-assisted surgery
- From:
International Journal of Surgery
2025;52(4):221-225
- CountryChina
- Language:Chinese
-
Abstract:
The evolution of surgical treatments for liver cancer—from traditional open surgery to robotic technology—marks a revolutionary advancement in hepatic surgery. This article focuses on robot-assisted laparoscopic hepatectomy (RALH), analyzing its technological breakthroughs, clinical challenges, and future prospects. Early minimally invasive techniques such as radiofrequency ablation (RFA) and transarterial chemoembolization (TACE) were limited by tumor location and complexity. In contrast, RALH overcomes the "chopstick effect" of traditional laparoscopy through three-dimensional high-definition visualization, flexible robotic arms, and multimodal navigation, enabling precise management of complex lesions in the hepatic hilar region and caudate lobe. Its indications encompass hepatocellular carcinoma, metastatic tumors, and benign lesions, with faster postoperative recovery. The widespread adoption of RALH faces three major challenges: high technical barriers (requiring a steep learning curve), prohibitive costs, and limited adaptability in emergency settings. Future efforts should integrate Artificial Intelligence (AI) to optimize surgical pathways, promote domestic robot production to reduce costs, and establish regional training centers to shorten the learning curve. Despite these bottlenecks, RALH has emerged as one of the pivotal breakthrough in hepatic surgery due to its precision and minimally invasive advantages. With advancing intelligence and multidisciplinary collaboration, it holds the potential to usher liver cancer treatment into a new era of individualized and precision medicine.
